Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Emetine Promotes von Hippel-Lindau-Independent Degradation of Hypoxia-Inducible Factor-2α in Clear Cell Renal Carcinoma

Hye-Sik Kong, Sunmin Lee, Kristin Beebe, Bradley Scroggins, Gopal Gupta, Min-Jung Lee, Yun-Jin Jung, Jane Trepel and Leonard Neckers
Molecular Pharmacology December 2010, 78 (6) 1072-1078; DOI: https://doi.org/10.1124/mol.110.066514
Hye-Sik Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunmin Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Beebe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley Scroggins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gopal Gupta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min-Jung Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yun-Jin Jung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane Trepel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Neckers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 78 no. 6 1072-1078
DOI 
https://doi.org/10.1124/mol.110.066514
PubMed 
20813864

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received May 19, 2010
  • Accepted September 2, 2010
  • Published online November 16, 2010.

Article Versions

  • Earlier version (September 2, 2010 - 08:14).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Hye-Sik Kong,
  2. Sunmin Lee,
  3. Kristin Beebe,
  4. Bradley Scroggins,
  5. Gopal Gupta,
  6. Min-Jung Lee,
  7. Yun-Jin Jung,
  8. Jane Trepel and
  9. Leonard Neckers
  1. Urologic Oncology Branch (H.K., K.B., B.S., G.G., L.N.) and Medical Oncology Branch (S.L., M.L., J.T.), Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (H.K.); and Laboratory of Biomedicinal Chemistry, College of Pharmacy, Pusan National University, Busan, Republic of Korea (Y.J.)
  1. Address correspondence to:
    Dr. Leonard Neckers, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892. E-mail: neckersl{at}mail.nih.gov
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2010 to March 2023

AbstractFullPdf
Oct 2010810177
Nov 20102521285
Dec 20102352745
Jan 2011702736
Feb 2011712043
Mar 2011622544
Apr 2011261118
May 201132620
Jun 2011432120
Jul 2011311924
Aug 2011281015
Sep 2011381021
Oct 201127921
Nov 201131821
Dec 201113924
Jan 2012231633
Feb 201225528
Mar 2012392530
Apr 2012311921
May 2012371319
Jun 201231724
Jul 2012151329
Aug 2012171314
Sep 2012302231
Oct 2012132437
Nov 2012251429
Dec 2012231418
Jan 2013201312
Feb 2013171514
Mar 2013221420
Apr 201337822
May 2013261223
Jun 20131159
Jul 2013191016
Aug 2013151013
Sep 20131174
Oct 2013678
Nov 201381710
Dec 2013131611
Jan 20141094
Feb 201412915
Mar 201472012
Apr 2014131410
May 20146168
Jun 201481910
Jul 2014171518
Aug 201462010
Sep 201418249
Oct 2014161066
Nov 2014164015
Dec 201411299
Jan 20157146
Feb 20151150
Mar 2015794
Apr 201562211
May 2015131410
Jun 2015101011
Jul 201513128
Aug 2015231818
Sep 20151194
Oct 20152115
Nov 20157715
Dec 20151502
Jan 201610926
Feb 20161248
Mar 201613313
Apr 2016641
May 20161242
Jun 20162108
Jul 20161166
Aug 2016181220
Sep 2016256
Oct 2016081
Nov 20161711
Dec 2016053
Jan 2017064
Feb 20170122
Mar 20170139
Apr 2017091
May 20170118
Jun 2017193
Jul 2017213
Aug 2017162
Sep 201731713
Oct 20176148
Nov 20173168
Dec 20175254
Jan 20187126
Feb 2018583
Mar 20183129
Apr 20182135
May 20183176
Jun 20184106
Jul 2018238
Aug 2018263
Sep 2018072
Oct 2018388
Nov 2018056
Dec 20181201
Jan 2019802
Feb 20191944
Mar 2019945
Apr 20191715
May 20191824
Jun 20191608
Jul 20191400
Aug 20191715
Sep 2019703
Oct 20191602
Nov 20192003
Dec 20192122
Jan 20203312
Feb 2020900
Mar 20201906
Apr 2020813
May 2020700
Jun 2020710
Jul 2020712
Aug 2020911
Sep 2020400
Oct 2020514
Nov 2020602
Dec 20201134
Jan 20211615
Feb 20211532
Mar 20212511
Apr 20213306
May 20213832
Jun 2021620
Jul 20211924
Aug 20211214
Sep 20211220
Oct 20211810
Nov 2021914
Dec 2021811
Jan 20222714
Feb 20221124
Mar 20221631
Apr 20221612
May 20221932
Jun 20222210
Jul 20221332
Aug 20221613
Sep 20221610
Oct 20222612
Nov 2022915
Dec 2022610
Jan 20231510
Feb 2023821
Mar 2023821

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 78 (6)
Molecular Pharmacology
Vol. 78, Issue 6
1 Dec 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Emetine Promotes von Hippel-Lindau-Independent Degradation of Hypoxia-Inducible Factor-2α in Clear Cell Renal Carcinoma
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Emetine Promotes von Hippel-Lindau-Independent Degradation of Hypoxia-Inducible Factor-2α in Clear Cell Renal Carcinoma

Hye-Sik Kong, Sunmin Lee, Kristin Beebe, Bradley Scroggins, Gopal Gupta, Min-Jung Lee, Yun-Jin Jung, Jane Trepel and Leonard Neckers
Molecular Pharmacology December 1, 2010, 78 (6) 1072-1078; DOI: https://doi.org/10.1124/mol.110.066514

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Emetine Promotes von Hippel-Lindau-Independent Degradation of Hypoxia-Inducible Factor-2α in Clear Cell Renal Carcinoma

Hye-Sik Kong, Sunmin Lee, Kristin Beebe, Bradley Scroggins, Gopal Gupta, Min-Jung Lee, Yun-Jin Jung, Jane Trepel and Leonard Neckers
Molecular Pharmacology December 1, 2010, 78 (6) 1072-1078; DOI: https://doi.org/10.1124/mol.110.066514
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics